ð¥Just publishedð¥
IDSA 2026 Clinical Practice Guideline Update on the Prevention of Invasive Aspergillosis in Adult Solid Organ Transplant Recipients #idxposts
https://t.co/44xeTMiLZp
Cerebral aspergillosis caused by Aspergillus flavus following seasonal influenza infection in a patient receiving ibrutinib for Waldenström's macroglobulinemia - https://t.co/a1iiyJ6zRD
äºåã«èããŠããè峿·±ãçäŸãJICæ²èŒããã§ãšãããããŸãð
This review article highlights how regulatory T cells can suppress acute and chronic #GVHD while preserving graft-versus-leukemia effects after #alloHCT. Early clinical studies demonstrate promising GVHD control low relapse rates and favorable survival. https://t.co/jd3taskfW5
frontMIND just published after great/streamlined presentation by Dr. Lenz et al showing a 2nd PhIII confirmed PFS over R-CHOP (after POLARIX) and appears as an impressive new/upcoming SOC option in #DLBCL#lymsm#ASCO26@Incyte https://t.co/FJLu11TER9
Revisiting Fluoroquinolone Prophylaxis in Hematological Malignancies and Hematopoietic Cell Transplantation: A Decade of Evidence and Gaps in Understanding the Impact of Gut Colonization with Fluoroquinolone-Resistant Enterobacterales
@IJAA_ISAC
https://t.co/5ROunVCl4B
Hepatitis B virus (#HBV) infection affects an estimated 254 million people worldwide and causes approximately 1.1 million deaths annually. ð§µ
HBV is a DNA virus transmitted through percutaneous or mucosal exposure to infected blood, semen, or body fluids. Acute HBV infection may resolve or progress to chronic infection, defined as persistence of #hepatitisB surface antigen (HBsAg) for more than 6 months.
ð Learn more in this JAMA Review: https://t.co/A2rfalCztZ